Tegaderm Vs. Transpore for Eye Protection During Anesthesia
Launched by TUFTS MEDICAL CENTER · Jun 2, 2021
Trial Information
Current as of April 29, 2025
Completed
Keywords
ClinConnect Summary
At Tufts Medical Center, a variety of adhesive tapes are used to shut the eyes during anesthesia, including 3MTM TegadermTM and the Sharn Anesthesia Transpore®, with no preference for one or the other. While all of these products decrease the risk of corneal abrasion, none of these products have been shown to be superior to the others in terms of eyelid irritation. According to Sharn Anesthesia, "The \[Transpore®\] adhesive is light enough to reduce damage to the outer eye" (3). However, there is no scientific evidence to support this claim. All the investigators know is that the Transpore ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least 18 years old
- • Surgeries scheduled for anesthesia of any duration
- Exclusion Criteria:
- • Any patient that does not consent
- * Any patient who has:
- • Pre-existing eyelid erythema or other eyelid trauma
- • Eyelid piercings
- • Any surgery on the head, brain, neck, teeth, mouth, eyes, or face
- • Surgery in the prone position
- • Patients less than 18 years old
About Tufts Medical Center
Tufts Medical Center is a leading academic medical institution located in Boston, Massachusetts, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a sponsor of clinical trials, Tufts Medical Center leverages its expertise in diverse medical disciplines to develop and test new therapies, enhance patient care, and contribute to the scientific community. With a focus on collaboration and rigorous methodologies, the center aims to translate research findings into practical applications that improve health outcomes for patients locally and globally. Its dedication to excellence is reflected in its partnerships with academic institutions, industry leaders, and healthcare organizations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials